Media Summary: This annual session is an opportunity for all interested stakeholders to get the latest information about priority initiatives and ... Welcome to The Pharma Podcast - here on this topic we will discuss the To mark the release of the fourth edition of the Guidelines for the Economic Evaluation of Health Technologies: Canada,

Cadth - Detailed Analysis & Overview

This annual session is an opportunity for all interested stakeholders to get the latest information about priority initiatives and ... Welcome to The Pharma Podcast - here on this topic we will discuss the To mark the release of the fourth edition of the Guidelines for the Economic Evaluation of Health Technologies: Canada, Don't miss our upcoming webinars: Subscribe today! This webinar was hosted by Gerry Jeffcott from 3Sixty Public Affairs. Speakers: Amanda Allard, Ph.D, Director of Pharmaceutical Reviews, Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This session will ...

On November 9, 2017, we were pleased to host nearly 400 people (in person and online) for our Evidence-to-Action event, ...

Photo Gallery

CADTH Drug Reimbursement Reviews
How Patient Input is Used by CADTH: Insights From Feedback Letters
Join CADTH and find your something more.
CADTH Drug Portfolio Information Session
CADTH - Streamlined Input Processes for Patients and Clinicians | Pharma | Biotech | Medtech
Release of the CADTH Health Economic Guidelines
CADTH Information Session - December 2022
WEBINAR: CDIAC Transition to CADTH
CADTH and INESSS and the future of HTA Processes
CADTH Webinar — How Patients Can Contribute to the CADTH Symposium
CADTH in Conversation with…. Professor Gillian Leng CBE, Chief Executive of NICE
CADTH Medical Device Portfolio Information Session
View Detailed Profile
CADTH Drug Reimbursement Reviews

CADTH Drug Reimbursement Reviews

CADTH

How Patient Input is Used by CADTH: Insights From Feedback Letters

How Patient Input is Used by CADTH: Insights From Feedback Letters

How Patient Input is Used by

Join CADTH and find your something more.

Join CADTH and find your something more.

Look no further. At

CADTH Drug Portfolio Information Session

CADTH Drug Portfolio Information Session

This annual session is an opportunity for all interested stakeholders to get the latest information about priority initiatives and ...

CADTH - Streamlined Input Processes for Patients and Clinicians | Pharma | Biotech | Medtech

CADTH - Streamlined Input Processes for Patients and Clinicians | Pharma | Biotech | Medtech

Welcome to The Pharma Podcast - here on this topic we will discuss the

Release of the CADTH Health Economic Guidelines

Release of the CADTH Health Economic Guidelines

To mark the release of the fourth edition of the Guidelines for the Economic Evaluation of Health Technologies: Canada,

CADTH Information Session - December 2022

CADTH Information Session - December 2022

The

WEBINAR: CDIAC Transition to CADTH

WEBINAR: CDIAC Transition to CADTH

Don't miss our upcoming webinars: Subscribe today! This webinar was hosted by Gerry Jeffcott from 3Sixty Public Affairs.

CADTH and INESSS and the future of HTA Processes

CADTH and INESSS and the future of HTA Processes

Speakers: Amanda Allard, Ph.D, Director of Pharmaceutical Reviews,

CADTH Webinar — How Patients Can Contribute to the CADTH Symposium

CADTH Webinar — How Patients Can Contribute to the CADTH Symposium

Patients are involved in every aspect of

CADTH in Conversation with…. Professor Gillian Leng CBE, Chief Executive of NICE

CADTH in Conversation with…. Professor Gillian Leng CBE, Chief Executive of NICE

On this episode of

CADTH Medical Device Portfolio Information Session

CADTH Medical Device Portfolio Information Session

Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This session will ...

CADTH Evidence-to-Action — Home-Based Dialysis in Canada

CADTH Evidence-to-Action — Home-Based Dialysis in Canada

On November 9, 2017, we were pleased to host nearly 400 people (in person and online) for our Evidence-to-Action event, ...